近视控制的风险与获益分析
该文分析近视控制方法的风险与获益。通过总结接触镜等控制方法的风险,并建立近视程度与视力损害风险的模型,估算延缓近视进展1D所能预防的视力损害年数。结论认为近视控制的潜在获益大于风险,预防5年视力损害需治疗人数为4.1至6.8,而因控制措施导致视力丧失的风险低于1/38。
要点
- 每增加1D近视,近视性黄斑病变、开角型青光眼、后囊下白内障和视网膜脱离风险分别增加58%、20%、21%和30%。
- 近视-3D者预测平均视力损害年数为4.42年,-8D者为9.56年;减少1D可分别降低0.74和1.21年。
- 预防5年视力损害的需治疗人数为4.1至6.8,而近视控制导致视力丧失的风险低于1/38。
核心结论
- 近视控制的潜在获益大于风险:预防5年视力损害的需治疗人数为4.1至6.8,而因控制措施导致视力丧失的风险低于1/38。
研究设计与样本
- 本文为分析性文章,首先总结各种近视控制方法(重点为接触镜佩戴)的已知风险,并基于现有数据估算不同发生率下视力损害风险及预测年数。
- 随后综述不同近视水平相关的威胁视力疾病风险,并建立视力损害风险随近视程度变化的模型,估算可预防的视力损害年数。
主要发现
- 假设微生物性角膜炎发生率为每1万患者年1至25例且15%病例导致视力丧失,则需38至945名患者暴露于5年佩戴才能产生5年视力丧失。
- 每增加1D近视,近视性黄斑病变、开角型青光眼、后囊下白内障和视网膜脱离的风险分别增加58%、20%、21%和30%。
- 预测平均视力损害年数从-3D者的4.42年至-8D者的9.56年,减少1D可分别降低0.74年和1.21年。
关键数值与推荐
- 微生物性角膜炎发生率假设为每1万患者年1至25例,其中15%病例导致视力丧失。
- 每增加1D近视,近视性黄斑病变风险增加58%,开角型青光眼风险增加20%,后囊下白内障风险增加21%,视网膜脱离风险增加30%。
- 预防5年视力损害的需治疗人数为4.1至6.8,而近视控制导致视力丧失的风险低于1/38。
临床怎么用
- 临床中可依据近视程度评估威胁视力疾病风险,并与患者讨论近视控制的获益与风险。
- 接触镜佩戴等控制方法需权衡微生物性角膜炎等风险,但总体获益大于风险。
局限性
- 风险估算基于假设的发生率(微生物性角膜炎每1万患者年1至25例)和15%视力丧失比例,可能受数据来源限制。
- 模型预测的视力损害年数依赖于现有数据,未涉及其他未测量因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The prevalence of myopia is increasing around the world, stimulating interest in methods to slow its progression. The primary justification for slowing myopia progression is to reduce the risk of vision loss through sight-threatening ocular pathologic features in later life. The article analyzes whether the potential benefits of slowing myopia progression by 1 diopter (D) justify the potential risks associated with treatments. METHODS: First, the known risks associated with various methods of myopia control are summarized, with emphasis on contact lens wear. Based on available data, the risk of visual impairment and predicted years of visual impairment are estimated for a range of incidence levels. Next, the increased risk of potentially sight-threatening conditions associated with different levels of myopia are reviewed. Finally, a model of the risk of visual impairment as a function of myopia level is developed, and the years of visual impairment associated with various levels of myopia and the years of visual impairment that could be prevented with achievable levels of myopia control are estimated. RESULTS: Assuming an incidence of microbial keratitis between 1 and 25 per 10 000 patient-years and that 15% of cases result in vision loss leads to the conclusion that between 38 and 945 patients need to be exposed to 5 years of wear to produce 5 years of vision loss. Each additional 1 D of myopia is associated with a 58%, 20%, 21%, and 30% increase in the risk of myopic maculopathy, open-angle glaucoma, posterior subcapsular cataract, and retinal detachment, respectively. The predicted mean years of visual impairment ranges from 4.42 in a person with myopia of -3 D to 9.56 in a person with myopia of -8 D, and a 1-D reduction would lower these by 0.74 and 1.21 years, respectively. CONCLUSIONS: The potential benefits of myopia control outweigh the risks: the number needed to treat to prevent 5 years of visual impairment is between 4.1 and 6.8, whereas fewer than 1 in 38 will experience a loss of vision as a result of myopia control.
引用
- Bullimore MA, Ritchey ER, Shah S, et al. The Risks and Benefits of Myopia Control. Ophthalmology. 2021. PMID: 33961969. doi:10.1016/j.ophtha.2021.04.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。